Elsevier

Neuroscience

Volume 119, Issue 3, 4 July 2003, Pages 831-838
Neuroscience

Sexual dimorphism for protein kinase cε signaling in a rat model of vincristine-induced painful peripheral neuropathy

https://doi.org/10.1016/S0306-4522(03)00203-3Get rights and content

Abstract

Painful peripheral neuropathy is a major dose-limiting adverse effect of many cancer chemotherapeutic agents, such as the vinca alkaloids and taxanes. Recent studies demonstrate sexual dimorphism in second-messenger signaling for primary afferent nociceptor sensitization, and a role of second messengers in the models of metabolic and toxic painful peripheral neuropathies. This study tested the hypothesis that sexual dimorphism alters the severity and second-messenger signaling pathways for enhanced nociception in an animal model of vincristine-induced painful peripheral neuropathy.

I.V. injection of vincristine induced mechanical hyperalgesia that was greater in female rats. Gonadectomy in the females but not the males abolished the sex-dependent difference in mechanical hyperalgesia; this effect of gonadectomy in females was reversed by estrogen replacement. Inhibition of protein kinase Cε (PKCε) attenuated vincristine-induced hyperalgesia in males and ovariectomized females, but not in normal females or in estrogen-replaced ovariectomized females. Inhibitors of protein kinase A, protein kinase G, p42/p44-mitogen activated protein kinase and nitric oxide synthase also attenuated vincristine-induced hyperalgesia, but to a similar degree in both sexes. These data demonstrate an estrogen-dependent sexual dimorphism in vincristine-induced hyperalgesia (female>male) and an unexpected opposite sexual dimorphism in the contribution of PKCε to the severity of this hyperalgesia (male>female).

Section snippets

Animals

Experiments were performed on male and female Sprague–Dawley rats (220–250 g, Bantin and Kingman, Fremont, CA, USA). Rats were housed in groups of two under a 12-h light/dark cycle. Food and water were available ad libitum. Experiments were carried out in accordance with NIH regulations for animal care and with the approval of the Institutional Animal Care and Use Committee of the University of California, San Francisco. All efforts were made to minimize the number of animals used and their

Vcr-induced mechanical hyperalgesia

A single i.v. injection of VCR, 50, 100 and 200 μg/kg, to male and female rats produced a dose-dependent decrease in nociceptive threshold that persisted for a period of at least 15 days. The magnitude of this mechanical hyperalgesia was greater in female rats at all doses and time points (Fig. 1A–C, n=8/group; Table 1).

Vcr-induced mechanical allodynia

Both male and female rats demonstrated a significant increase in paw-withdrawal frequency in response to 1.3-, 3.6-, 10- and 27.5-mN von Frey stimulation, tested 5 days after a

Discussion

Vinca alkaloids such as VCR, are widely used alone or in combination with other chemotherapeutic agents in the treatment of many different malignancies including breast cancer, leukemias, lymphomas, and primary brain tumors Di Cataldo et al., 2002, Ito et al., 2002, Kochi and Ushio, 2002, Robak et al., 2002. VCR kills mitotically active cells by binding tubulin and preventing microtubule formation in mitotic spindles Mahboobi et al., 2001, Blajeski et al., 2002. Tumor cells are most effectively

Acknowledgements

Funded by NIH grant DE08973. We thank Dr. Robert Gear for his helpful suggestions and assistance in the statistical analysis of the data.

References (68)

  • J.A. DeLeo et al.

    Gender differences in rat neuropathic pain sensitivity is dependent on strain

    Neurosci Lett

    (2000)
  • S.E. Eaton et al.

    Spinal-cord involvement in diabetic peripheral neuropathy

    Lancet

    (2001)
  • G. Favaro et al.

    Ganglioside treatment of vincristine-induced neuropathyan electrophysiologic study

    Toxicology

    (1988)
  • K. Hayakawa et al.

    NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGF treatment schedulein vitro study of adult rat sympathetic ganglion explants

    Brain Res

    (1998)
  • K. Hayakawa et al.

    Nerve growth factor prevents neurotoxic effects of cisplatin, vincristine and taxol, on adult rat sympathetic ganglion explants in vitro

    Life Sci

    (1994)
  • D.V. Jackson et al.

    Amelioration of vincristine neurotoxicity by glutamic acid

    Am J Med

    (1988)
  • E. Kinnman et al.

    Sensory and sympathetic contributions to nerve injury-induced sensory abnormalities in the rat

    Neuroscience

    (1995)
  • E. Kondo et al.

    Involvement of glutamate receptors on hyperexcitability of wide dynamic range neurons in the gracile nucleus of the rats with experimental mononeuropathy

    Pain

    (2002)
  • P.N. Konings et al.

    Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro

    Brain Res

    (1994)
  • A. Lachowicz et al.

    Gender differences in steroid modulation of angiotensin II-induced protein kinase C activity in anterior pituitary of the rat

    Biochem Biophys Res Commun

    (2002)
  • G.M. McCarthy et al.

    Jaw and other orofacial pain in patients receiving vincristine for the treatment of cancer

    Oral Surg Oral Med Oral Pathol

    (1992)
  • T. Mosconi et al.

    Fixed-diameter polyethylene cuffs applied to the rat sciatic nerve induce a painful neuropathyultrastructural morphometric analysis of axonal alterations

    Pain

    (1996)
  • N. Nozaki-Taguchi et al.

    Vincristine-induced allodynia in the rat

    Pain

    (2001)
  • R.E. Papka et al.

    Localization of estrogen receptor protein and estrogen receptor messenger RNA in peripheral autonomic and sensory neurons

    Neuroscience

    (1997)
  • R.E. Papka et al.

    Estrogen receptor-alpha and -beta coexist in a subpopulation of sensory neurons of female rat dorsal root ganglia

    Neurosci Lett

    (2002)
  • Z. Schwartz et al.

    Tamoxifen elicits its anti-estrogen effects in growth plate chondrocytes by inhibiting protein kinase C

    J Steroid Biochem Mol Biol

    (2002)
  • J.M. Tall et al.

    Gender and the behavioral manifestations of neuropathic pain

    Pharmacol Biochem Behav

    (2001)
  • R.D. Treede et al.

    Peripheral and central mechanisms of cutaneous hyperalgesia

    Prog Neurobiol

    (1992)
  • H. Wei et al.

    A differential modulation of allodynia, hyperalgesia and nociception by neuropeptide FF in the periaqueductal gray of neuropathic ratsinteractions with morphine and naloxone

    Neuroscience

    (1998)
  • K.O. Aley et al.

    Role of protein kinase A in the maintenance of inflammatory pain

    J Neurosci

    (1999)
  • K.O. Aley et al.

    Nociceptor sensitization by extracellular signal-regulated kinases

    J Neurosci

    (2001)
  • K.O. Aley et al.

    Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C

    J Neurosci

    (2000)
  • K.J. Berkley

    Sex differences in pain

    Behav Brain Sci

    (1997)
  • H. Bester et al.

    Changes in tactile stimuli-induced behavior and c-Fos expression in the superficial dorsal horn and in parabrachial nuclei after sciatic nerve crush

    J Comp Neurol

    (2000)
  • Cited by (62)

    • ThermoTRP channels in pain sexual dimorphism: new insights for drug intervention

      2022, Pharmacology and Therapeutics
      Citation Excerpt :

      In particular, testosterone concentration in the sciatic nerve was higher in males whereas 17-β-estradiol and progesterone derivatives (dihydroprogesterone, tetrahydroprogesterone) were increased in females, suggesting that a specific hormonally-activated pathway may be predominating in each sex. An estrogen-dependent sexual dimorphism was also found in rats treated with vincristine, where removal of the hormone abolished the greater mechanical hypersensitivity found in female rats when compared to males (Joseph & Levine, 2003). In this study, inhibition of PKC-ε, a modulator of TRPV1 activity, reduced vincristine-induced hyperalgesia in males and ovariectomized females (Joseph & Levine, 2003), suggesting that estrogens could generate hyperalgesia in females by promoting TRPV1 signaling (Goswami et al., 2011).

    • Aromatase inhibitors augment nociceptive behaviors in rats and enhance the excitability of sensory neurons

      2016, Experimental Neurology
      Citation Excerpt :

      Our observed differences in the time course of nociceptive behavior between males and OVX females given the treatment regimens could be secondary to sex differences mediating nociception and analgesia, as have been suggested by many clinical and pre-clinical pain studies (Craft et al., 2004). For example, differences between males and females have been observed in the nociceptive response to capsaicin (Lu et al., 2009), in animal models of chemotherapy-induced peripheral neuropathy (Joseph and Levine, 2003), and in nociceptive changes due to inflammation (Mannino et al., 2007). These differences are often attributed to multiple factors, including the organizational and activational consequences of reproductive hormone differences between sexes.

    View all citing articles on Scopus
    View full text